Inventor
David V. Goeddel
Inventor
Hillsborough, CA, US
Overview
Patents· 96 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C12YEnzymes7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms2%
PatentTitleYear
11,052,066Ultrapure tetrahydrocannabinol-11-oic acids202110,369,131Ultrapure tetrahydrocannabinol-11-oic acids201910,154,986Ultrapure tetrahydrocannabinol-11-oic acids201810,085,964Ultrapure tetrahydrocannabinol-11-oic acids20187,754,858'Antibodies to tumor necrosis factor receptor associated factor polypeptides'20107,528,244'Regulators of apoptosis'20097,244,836'Tumor necrosis factor receptor-associated factors'20077,029,871'RIP: a human protein involved in tumor necrosis factor signal transduction'20066,964,765'Inhibitors of apoptosis'20056,855,815'Inhibitors of apoptosis'20056,838,550'Suppressors of death domains'20056,821,736'Inhibitors of apoptosis'20046,822,138'NIK-knockout mice'20046,673,343'SAL-S1 receptor protein tyrosine kinase agonist antibodies'20046,610,830'Microbial production of mature human leukocyte interferons'20036,500,922'Tumor necrosis factor receptor-associated factors'20026,482,613'Microbial production of mature human leukocyte interferons'20026,437,113'Suppressors of death domains'20026,432,677'Non-human animal interferons'20026,413,728'Methods for detecting SODD genes and proteins'20026,331,302'Protein tyrosine kinase agonist antibodies'20016,294,348'TRAF inhibitors'20016,284,247'Human tissue plasminogen activators'20016,274,335'Method of treatment using recombinant human tissue plasminogen activator'20016,261,837'Human tPA production using vectors coding for DHFR protein'20016,242,569'Regulators of apoptosis'20016,211,337'RIP: novel human protein involved in tumor necrosis factor signal transduction'20016,187,557'c-IAP1 and c-IAP2: inhibitors of apoptosis'20016,110,690'SODD-specific antibodies and methods'20006,063,585'TRAF Inhibitors'20006,060,303'TRAF inhibitors'20006,004,553'TRAF inhibitors'19995,939,302'IKK-.beta. proteins, nucleic acids and methods'19995,916,760'IKK-.beta. proteins, nucleic acids and methods'19995,869,314'Tissue plasminogen activators and derivatives thereof as produced by recombinant means'19995,869,612'Tumor necrosis factor receptor-associated factors'19995,851,812'IKK-.beta. proteins, nucleic acids and methods'19985,849,574'Human tPA production using vectors coding for DHFR protein'19985,843,422'Method and compositions for treating injury'19985,831,023'Recombinant animal interferon polypeptides'19985,827,694'DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides'19985,801,231'Nucleic acid encoding TGF-.beta. and its uses'19985,795,745'Human growth hormone'19985,789,550'TRAF inhibitors'19985,767,244'Protein-TRAF6'19985,763,253'Methods of preparing tissue plasiminogen activator derivative composition'19985,753,486'Human tissue plasminogen activator'19985,747,023'Cancer therapy using lymphotoxin'19985,741,667'Tumor necrosis factor receptor-associated factors'19985,736,135'Method for making variant secreted proteins with altered properties'19985,728,566'Tissue plasminogen activator derivatives'19985,728,565'Methods of preparing tissue plasminogen activator derivatives'19985,725,851'Method and compositions for treating injury'19985,710,013'Tumor necrosis factor receptor associated factor 6 (TRAF6)'19985,708,142'Tumor necrosis factor receptor-associated factors'19985,702,938'Human tissue plasminogen activator'19975,670,319'Assay for tumor necrosis factor receptor-associated factors'19975,654,397'Interleukin-1 receptor-associated protein kinase and assays'19975,635,177'Protein tyrosine kinase agonist antibodies'19975,587,159'Human tissue plasminogen activator'19965,582,824'Recombinant DES-CYS-TYR-CYS human immune interferon'19965,563,039'TNF receptor-associated intracellular signaling proteins and methods of use'19965,482,851'Nucleic acid encoding TGF-.beta. and its uses'19965,460,811'Mature human fibroblast interferon'19955,424,198'Human tPA production using vectors coding for DHFR protein'19955,424,199'Human growth hormone'19955,352,587'Compositions and methods for the synthesis of natriuretic protein receptor B and methods of use'19945,284,763'Nucleic acid encoding TGF-.beta. and its uses'19945,268,291'Human t-PA production using vectors coding for DHFR protein'19935,231,176'Distinct family DNA encoding of human leukocyte interferons'19935,223,408'Method for making variant secreted proteins with altered properties'19935,200,176'Method for protection of ischemic tissues using tumor nerosis factor'19935,185,259'Truncated human tissue plasminogen activator'19935,168,051'Nucleic acid encoding TGF-.beta. its uses'19925,120,832'Distinct family of human leukocyte interferons'19925,096,705'Human immune interferon'19925,011,795'Human tPA production using vectors coding for DHFR protein'19914,929,554'Human immune interferon'19904,925,793'Human immune interferon'19904,898,830'Human growth hormone DNA'19904,886,747'Nucleic acid encoding TGF-.beta. and its uses'19894,853,330'Human tissue plasminogen activator'19894,810,645'Microbial production of mature human leukocyte interferon K and L'19894,801,685'Microbial production of mature human leukocyte interferon K and L'19894,766,075'Human tissue plasminogen activator'19884,762,791'Human immune interferon'19884,742,003'Human transforming growth factor'19884,727,138'Human immune interferon'19884,678,751'Hybrid human leukocyte interferons'19874,658,021'Methionyl human growth hormone'19874,634,677'Plasmid capable of expressing human growth hormone'19874,604,359'Microbial expression of a gene for human growth hormone'19864,601,980'Microbial expression of a gene for human growth hormone'19864,456,748'Hybrid human leukocyte interferons'19844,414,150'Hybrid human leukocyte interferons'19834,342,832'Method of constructing a replicable cloning vehicle having quasi-synthetic genes'1982Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1982–2010Patents assigned to GENENTECH INC (71)· patent assignee history
1982–2003Based in Burlingame, CA, US· patent location history
1988–2010Based in Hillsborough, CA, US· patent location history
1989–2003Patents assigned to HOFFMANN LA ROCHE (4)· patent assignee history
1996–2002Patents assigned to TULARIK INC (18)· patent assignee history
1998Based in Hillborough, CA, US· patent location history
2004–2009Patents assigned to AMGEN INC (6)· patent assignee history
2018–2021Patents assigned to CORBUS PHARMACEUTICALS INC (4)· patent assignee history
2018–2019Based in Madison, WI, US· patent location history
2021Based in Madison, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 71 | 1982–2010 |
| TULARIK INC | 18 | 1996–2002 |
| AMGEN INC | 6 | 2004–2009 |
| CORBUS PHARMACEUTICALS INC | 4 | 2018–2021 |
| HOFFMANN LA ROCHE | 4 | 1989–2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hillsborough, California, US | 66 | 1988–2010 |
| Burlingame, California, US | 22 | 1982–2003 |
| Madison, WI, US | 3 | 2018–2019 |
| Madison, New Jersey, US | 1 | 2021 |
| Hillborough, California, US | 1 | 1998 |